Terms of Use

1. Terms and Conditions of Use:

These website terms and conditions of use apply to the use of -the website operated by WCA, a American based not-for- profit organisation and - any and all ‘content’ from the website such as scientific, technical, contractual, product, programme, pricing information; news, educational materials, publications, guides, presentations, abstracts; other information available on the website such as data, text, software, music, sound, photographs, graphics, video, messages, and other materials. WCA reserves the right to amend these terms & conditions at its sole discretion, without prior notice, on condition that details of the amendments are published on the WCA website. They become effective from the time of posting. Use of the website after the posting constitutes acceptance of the modified terms & conditions. Please read the terms carefully. The terms are entered into by and between the user and WCA, and the user accepts them by using the website in any manner and/or by otherwise acknowledging his/her agreement with the terms. If the user doesn’t agree to all the terms, he/she should not use the website. Should you require further information or have comments on WCA terms & conditions,
please contact us at: WCA Office - Research Fringe 94 St. Albans Road, Watford, Hertfordshire WD17 1SJ, United Kingdom. Tel:+44-(0)-208-638-5556

2. Copyright - Intellectual Property
  • The WCA website is owned by WCA. All content owned by WCA on the WCA website is copyrighted under Belgian and International law. All rights in content on the WCA website (including without limitation all articles, statements, texts, images, logos and design) are owned by or licensed to the WCA exclusively. All rights are expressly reserved by WCA.
  • Use of and access to any content licensed to WCA by third parties is subject to any additional terms or conditions of use which may apply. Any additional terms will usually be made available at the point at which one obtains or registers to access such content. By accessing such content, one agrees to comply with such additional terms of use, if any. Such licensed content may only be used in accordance with those additional terms as well as in accordance with these terms. If you have any questions regarding the ownership or use of content on the website, please contact WCA at the address below.
  • Any content may be copied and distributed on a limited basis for non-commercial purposes only, provided that any material copied remains intact and that all copies include the following 2 notices in a clearly visible position: “Copyright © WCA. All rights reserved”, as well as links to www.worldcanceractions.com where appropriate. These materials may only be used for personal use.
  • Copy, modification or use of any content included on the WCA website for any commercial purpose without the authorisation of WCA is a violation of patent, copyright and other proprietary rights including intellectual property rights owned by WCA and/or its contributors. Any copying or redistribution for commercial purposes or for compensation of any kind requires prior written permission from WCA.
  • The use of the WCA Logo and WCA corporate visuals (including, but not limited to, graphics, images, videos…) is subject to written authorisation by WCA. Any unapproved use may result in actions being taken by WCA to require removal of material concerned from display/ distribution and possible legal action.
3. General Conditions:
User registration:

User registration, via ‘PayPal’, is required to access personal services online and certain online content. The user is responsible for maintaining the confidentiality of his/her account login details. The user registration is unique and personal. It should not be shared with anyone. WCA shall not be held responsible for unauthorised use of the user’s account by a third party to whom the user may have, intentionally or not, disclosed his/her account login details.

Unavailability/Force Majeure:

WCA disclaims all responsibilities for the unavailability of the WCA website and services caused by conditions beyond its control including, but not limited to Acts of God, Government restrictions, wars, insurrections and/or any other cause beyond the reasonable control of WCA.

Disclaimer:

WCA cannot endorse all statements or opinions made on the website.Regardless of the vast professional knowledge and scientific expertise in the field of science and technology that WCA possesses, the Society cannot inspect all information to determine the truthfulness, accuracy, reliability, completeness or relevancy thereof. Furthermore, WCA cannot endorse all statements or opinions made on the WCA website. Under no circumstances will WCA be held liable for any decision taken or acted upon as a result of reliance on the content of the WCA website. The component information of the WCA website is not intended or implied to be a substitute for professional medical advice or medical care. The advice of a medical professional should always be sought prior to commencing any form of medical treatment. To this end, all component information contained within the website is done so for solely educational and scientific purposes. WCA and all of its staff, agents and members disclaim any and all warranties and representations with regards to the information contained on the WCA Website. This includes any implied warranties and conditions that may be derived from the aforementioned website information.

Liability:

Under no circumstances will WCA or any affiliated staff or partners or website contributors, be liable to you, as a website visitor or any other person or body, for any decision taken or acted upon as a result of reliance on the information or philosophies contained or expressed within the WCA website. You agree that neither WCA nor any affiliated staff or partners or website contributors, will be responsible for any loss or damage (including, without limitation, direct, indirect, incidental, 4 special or consequential damages), or loss of data or loss of profit, even if the WCA or any affiliated staff or website contributors, has been advised of the possibility of such loss. No agency, partnership, joint venture, employee-employer or franchiser-franchisee relationship between the member and WCA is intended or created by these terms and conditions.

Privacy Policy

We process your personal data in accordance with applicable laws and regard your privacy as highly valuable. By using the web services of WCA, you acknowledge and agree that your personal data will be treated and processed as described in our privacy policy.

Hardik Gandhi

Cadila Healthcare Ltd., India

Oncologists' Attitudes Towards the Usage of G-Csf Derivatives - a Global Perspective

Timur Koca

 

Endemic Causes of Esophageal Squamous Cell Cancer

Anupam

Netaji Subhash Engineering College, India

Cancer Mediating Biomarker Identification Using Machine Learning Algorithms

Cheng-Wen Wu

National Yang-Ming University, Taiwan

Targeting Bmi1 And Mcl1 for Lung Adenocarcinoma Treatment

Lital Keinan-Boker

Israel Center for Disease Control, Israel Ministry of Health, Israel

Adverse Health-Related Outcomes of Treatment in an Israeli Cohort of Breast Cancer Survivors

Perreault Claude

Université de Montréal, Canada

The Nature of Tumor-Specific Antigens

Victoria Blanes-Vidal

University of Southern Denmark, Denmark

Capsule Endoscopy Evaluation of Colorectal Polyps

Eric M Massicotte

University of Toronto, Canada

Mass in Metastatic Spine Disease

Esmaeil S Nadimi

University of Southern Denmark, Denmark

Autonomous Characterisation of Colorectal Polyps

Jorge Federico Ferreira Parker

Universidad De Chile, Chile

Derivatives of Alkyl Gallate Triphenylphosphonium Exhibit Antitumor Activity in a Orthotopic Xenograft Model of Human Breast Cancer

John F. McDonald

Universidad De Chile, Chile

Machine Learning in the Treatment of Cancer

John F. McDonald

Georgia Institute of Technology, USA

Machine Learning in the Treatment of Cancer

David I Smith

Mayo Clinic, USA

The DNA Sequencing Revolution and Oncology

RS Ruan

Xiamen University, China

Rational Combinations of Active and Passive Immunotherapy Mobilize Immune and Clinical Responses in Terminal Cancers

Di Giorgio Marina

Autoridad Regulatoria Nuclear, Argentina"

Monitoring Advetitious Radiation Exposure In Radiotherapy- ‘Second Primary Cancers’ Attributable To Radiotherapy

Final
Program

May 08-09, 2019